Deferoxamine synergizes with transforming growth factor-β signaling in chondrogenesis

Deferoxamine synergizes with transforming growth factor-β signaling in chondrogenesis

Abstract Osteoarthritis, also known as degenerative arthritis or degenerative joint disease, is an epidemic disease that affects millions of people worldwide. Despite extensive recent work on the cellular biology of osteoarthritis, the precise mechanisms involved are still poorly understood and ther...

Full description

Bibliographic Details
Main Authors:	Zheng Huang, Guangxu He, Yanke Huang
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Genética 2017-08-01
Series:	Genetics and Molecular Biology
Subjects:	chondrogenesis deferoxamine osteoarthritis TGF-β
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572017000400698&lng=en&tlng=en

Similar Items

Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway
by: Zhou Guo, et al.
Published: (2022-03-01)

Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway
by: Zhou Guo, et al.
Published: (2023-05-01)

Mesenchymal stromal cell chondrogenesis under ALK1/2/3-specific BMP inhibition: a revision of the prohypertrophic signalling network concept
by: Solvig Diederichs, et al.
Published: (2024-04-01)

BMP2 and TGF-β Cooperate Differently during Synovial-Derived Stem-Cell Chondrogenesis in a Dexamethasone-Dependent Manner
by: Nikolas J. Kovermann, et al.
Published: (2019-06-01)

Deferoxamine-Based Materials and Sensors for Fe(III) Detection
by: Giancarla Alberti, et al.
Published: (2022-11-01)

An overview of complications associated with deferoxamine therapy in thalassemia
by: Bijan Keikhaei, et al.
Published: (2021-01-01)

Temporal TGF-β Supergene Family Signalling Cues Modulating Tissue Morphogenesis: Chondrogenesis within a Muscle Tissue Model?
by: Fei Xiong, et al.
Published: (2020-07-01)

Application of Some Herbal Medicine Used for the Treatment of Osteoarthritis and Chondrogenesis
by: Morteza Anvari, et al.
Published: (2020-09-01)

The Role of MicroRNA-381 in Chondrogenesis and Interleukin-1-β Induced Chondrocyte Responses
by: Changhe Hou, et al.
Published: (2015-07-01)

In Vitro Chondrogenesis Induction by Short Peptides of the Carboxy-Terminal Domain of Transforming Growth Factor β1
by: Maria Pitou, et al.
Published: (2023-11-01)

Decreased expression of GEM in osteoarthritis cartilage regulates chondrogenic differentiation via Wnt/β-catenin signaling
by: Lu Gan, et al.
Published: (2023-10-01)

Comparison of deferasirox and deferoxamine effect on liver enzyme activities and ferritin level in patients with beta-thalassemia
by: Rasul Jameel Ali, et al.
Published: (2020-12-01)

Synergistic Effects of Kartogenin and Transforming Growth Factor‐β3 on Chondrogenesis of Human Umbilical Cord Mesenchymal Stem Cells In Vitro
by: Yanhong Zhao, et al.
Published: (2020-06-01)

Malat1 attenuated the rescuing effects of docosahexaenoic acid on osteoarthritis treatment via repressing its chondroprotective and chondrogenesis activities
by: Lu Feng, et al.
Published: (2022-10-01)

Potential of Using Infrapatellar–Fat–Pad–Derived Mesenchymal Stem Cells for Therapy in Degenerative Arthritis: Chondrogenesis, Exosomes, and Transcription Regulation
by: Hsiu-Jung Liao, et al.
Published: (2022-03-01)

Effects of insulin-like growth factor-induced Wharton jelly mesenchymal stem cells toward chondrogenesis in an osteoarthritis model
by: Wahyu Widowati, et al.
Published: (2018-07-01)

Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/β-catenin pathway
by: Hao Yu, et al.
Published: (2021-05-01)

Physioxia Has a Beneficial Effect on Cartilage Matrix Production in Interleukin-1 Beta-Inhibited Mesenchymal Stem Cell Chondrogenesis
by: Girish Pattappa, et al.
Published: (2019-08-01)

The Effect of Biomolecular Gradients on Mesenchymal Stem Cell Chondrogenesis under Shear Stress
by: Alexander L. Rivera, et al.
Published: (2015-03-01)

TGFβ1-transfected tendon stem cells promote tendon fibrosis
by: Hong-Bin Yu, et al.
Published: (2022-07-01)

Combining biomechanical stimulation and chronobiology: a novel approach for augmented chondrogenesis?
by: Judit Vágó, et al.
Published: (2023-06-01)

Application of the technique of autologous matrix-induced chondrogenesis in the treatment of patients with osteoarthritis of the first metatarsophalangeal joint
by: Maxim R. Nurmukhametov, et al.
Published: (2021-04-01)

Cardioprotective effects of deferoxamine in acute and subacute cardiotoxicities of doxorubicin: a randomized clinical trial
by: Kosar Rahimi, et al.
Published: (2023-03-01)

Evaluation of transforming growth factor beta 1 in dogs with osteoarthritis
by: Stephan Neumann, et al.
Published: (2018-10-01)

Deferoxamine as a potential cause of incidentally found T1-hyperintense urine on magnetic resonance imaging
by: Trishae Winters, BS, et al.
Published: (2022-01-01)

Interactions of Alginate-Deferoxamine Conjugates With Blood Components and Their Antioxidation in the Hemoglobin Oxidation Model
by: Tong Sun, et al.
Published: (2020-02-01)

Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature
by: Constantine D. Georgakopoulos, et al.
Published: (2018-09-01)

Sustained-release losartan from peptide nanofibers promotes chondrogenesis
by: Kohei Yamaura, et al.
Published: (2023-02-01)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
by: Wu D, et al.
Published: (2018-05-01)

Hypoxic Conditions Modulate Chondrogenesis through the Circadian Clock: The Role of Hypoxia-Inducible Factor-1α
by: Krisztián Zoltán Juhász, et al.
Published: (2024-03-01)

Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage
by: Zhe Li, et al.
Published: (2022-06-01)

Preparation and characterization of topical solid lipid nanoparticles containing deferoxamine
by: Behzad Sharif Makhmalzade, et al.
Published: (2021-09-01)

Evaluation of the relationship of echocardiographic left vantricular mass to amounts of transfusions of packed cell and Deferoxamine in Thalassemia major
by: "Kocharian A, et al.
Published: (2001-05-01)

Evaluation of the relationship of echocardiographic left vantricular mass to amounts of transfusions of packed cell and Deferoxamine in Thalassemia major
by: "Kocharian A, et al.
Published: (2001-03-01)

Urinary iron excretion induced by intravenous infusion of deferoxamine in ß-thalassemia homozygous patients
by: Boturão-Neto E., et al.
Published: (2002-01-01)

Transdermal deferoxamine administration improves excisional wound healing in chronically irradiated murine skin
by: Hendrik Lintel, et al.
Published: (2022-06-01)

Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
by: Jacob Kosyakovsky, et al.
Published: (2021-01-01)

Deferoxamine Reduces Inflammation and Osteoclastogenesis in Avulsed Teeth
by: Ko Eun Lee, et al.
Published: (2021-07-01)

The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity
by: Masanari Umemura, et al.
Published: (2017-08-01)

MicroRNA-378 contributes to osteoarthritis by regulating chondrocyte autophagy and bone marrow mesenchymal stem cell chondrogenesis
by: Lu Feng, et al.
Published: (2022-06-01)